rs143671872

Variant summary

Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2

The NM_000135.4(FANCA):​c.3430C>T​(p.Arg1144Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000787 in 1,614,000 control chromosomes in the GnomAD database, including 2 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00045 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00082 ( 2 hom. )

Consequence

FANCA
NM_000135.4 missense

Scores

9
10

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:13B:1

Conservation

PhyloP100: 0.864
Variant links:
Genes affected
FANCA (HGNC:3582): (FA complementation group A) The Fanconi anemia complementation group (FANC) currently includes FANCA, FANCB, FANCC, FANCD1 (also called BRCA2), FANCD2, FANCE, FANCF, FANCG, FANCI, FANCJ (also called BRIP1), FANCL, FANCM and FANCN (also called PALB2). The previously defined group FANCH is the same as FANCA. Fanconi anemia is a genetically heterogeneous recessive disorder characterized by cytogenetic instability, hypersensitivity to DNA crosslinking agents, increased chromosomal breakage, and defective DNA repair. The members of the Fanconi anemia complementation group do not share sequence similarity; they are related by their assembly into a common nuclear protein complex. This gene encodes the protein for complementation group A. Alternative splicing results in multiple transcript variants encoding different isoforms. Mutations in this gene are the most common cause of Fanconi anemia. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -4 ACMG points.

BS2
High Homozygotes in GnomAdExome4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
FANCANM_000135.4 linkuse as main transcriptc.3430C>T p.Arg1144Trp missense_variant 35/43 ENST00000389301.8 NP_000126.2 O15360-1
FANCANM_001286167.3 linkuse as main transcriptc.3430C>T p.Arg1144Trp missense_variant 35/43 NP_001273096.1 O15360-3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
FANCAENST00000389301.8 linkuse as main transcriptc.3430C>T p.Arg1144Trp missense_variant 35/431 NM_000135.4 ENSP00000373952.3 O15360-1

Frequencies

GnomAD3 genomes
AF:
0.000453
AC:
69
AN:
152200
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000724
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000188
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000911
Gnomad OTH
AF:
0.000478
GnomAD3 exomes
AF:
0.000525
AC:
132
AN:
251310
Hom.:
0
AF XY:
0.000501
AC XY:
68
AN XY:
135842
show subpopulations
Gnomad AFR exome
AF:
0.0000615
Gnomad AMR exome
AF:
0.000260
Gnomad ASJ exome
AF:
0.000198
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000131
Gnomad FIN exome
AF:
0.000232
Gnomad NFE exome
AF:
0.000959
Gnomad OTH exome
AF:
0.000326
GnomAD4 exome
AF:
0.000822
AC:
1202
AN:
1461800
Hom.:
2
Cov.:
32
AF XY:
0.000787
AC XY:
572
AN XY:
727198
show subpopulations
Gnomad4 AFR exome
AF:
0.0000896
Gnomad4 AMR exome
AF:
0.000268
Gnomad4 ASJ exome
AF:
0.000115
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.000139
Gnomad4 FIN exome
AF:
0.000394
Gnomad4 NFE exome
AF:
0.00100
Gnomad4 OTH exome
AF:
0.000596
GnomAD4 genome
AF:
0.000453
AC:
69
AN:
152200
Hom.:
0
Cov.:
32
AF XY:
0.000336
AC XY:
25
AN XY:
74354
show subpopulations
Gnomad4 AFR
AF:
0.0000724
Gnomad4 AMR
AF:
0.0000654
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.000188
Gnomad4 NFE
AF:
0.000911
Gnomad4 OTH
AF:
0.000478
Alfa
AF:
0.000641
Hom.:
0
Bravo
AF:
0.000453
TwinsUK
AF:
0.000809
AC:
3
ALSPAC
AF:
0.00182
AC:
7
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00128
AC:
11
ExAC
AF:
0.000642
AC:
78
EpiCase
AF:
0.000491
EpiControl
AF:
0.000652

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:13Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Fanconi anemia complementation group A Pathogenic:1Uncertain:4
Uncertain significance, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsOct 31, 2018- -
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
Uncertain significance, no assertion criteria providedclinical testingNatera, Inc.Sep 16, 2020- -
Pathogenic, no assertion criteria providedcurationLeiden Open Variation DatabaseFeb 28, 2020Curator: Arleen D. Auerbach. Submitter to LOVD: Johan de Winter. -
Uncertain significance, criteria provided, single submitterclinical testingBaylor GeneticsJan 07, 2020This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. -
not provided Uncertain:4
Uncertain significance, criteria provided, single submitterclinical testingInstitute for Clinical Genetics, University Hospital TU Dresden, University Hospital TU DresdenNov 03, 2021- -
Uncertain significance, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, Amsterdam University Medical Center-- -
Uncertain significance, criteria provided, single submitterclinical testingQuest Diagnostics Nichols Institute San Juan CapistranoOct 03, 2024The FANCA c.3430C>T (p.Arg1144Trp) variant has been reported in the published literature in individuals affected with colorectal cancer and leiomyosarcoma (PMID: 32659967 (2020)), breast cancer (PMID: 30086788 (2018)), and ovarian cancer (PMID: 32546565 (2021)). The variant has also been reported in an individual with Fanconi Anemia (PMID: 22778927 (2012)) as well as reportedly healthy individuals (PMID: 14695169 (2003), 29641532 (2018)). The frequency of this variant in the general population, 0.00093 (120/129114 chromosomes in European (Non-Finnish) subpopulation (Genome Aggregation Database, http://gnomad.broadinstitute.org)), is higher than would generally be expected for pathogenic variants in this gene. Analysis of this variant using bioinformatics tools for the prediction of the effect of amino acid changes on protein structure and function yielded predictions that this variant is damaging. Based on the available information, we are unable to determine the clinical significance of this variant. -
Uncertain significance, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
not specified Uncertain:3
Uncertain significance, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoFeb 03, 2017- -
Uncertain significance, criteria provided, single submitterclinical testingCenter for Genomic Medicine, Rigshospitalet, Copenhagen University HospitalJul 31, 2024- -
Uncertain significance, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpJan 16, 2024Variant summary: FANCA c.3430C>T (p.Arg1144Trp) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00079 in 1,607,004 control chromosomes, predominantly at a frequency of 0.001 within the Non-Finnish European subpopulation in the gnomAD database (v4 dataset), including 2 homozygotes. This frequency is not higher than the estimated maximum expected for a pathogenic variant in FANCA causing Fanconi Anemia (0.0022), however, the presence of the variant in homozygotes, suggests that it might be benign when found in homozygous state. On the other hand, the variant c.3430C>T, has been reported in the literature in a compound heterozygous individual affected with Fanconi Anemia (Gille_2012), who carried a likely pathogenic FANCA variant, although the phase of these variants was not provided. In addition, the variant has been reported in heterozygous state in patients affected with breast cancer and other tumor phenotypes (e.g Penkert_2018, de Angelis de Carvalho_2020). These reports do not provide unequivocal conclusions about association of the variant with Fanconi Anemia. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 22778927, 30086788, 32659967). ClinVar contains an entry for this variant (Variation ID: 408171). Based on the evidence outlined above, the variant was classified as uncertain significance. -
Fanconi anemia Uncertain:1Benign:1
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 25, 2024- -
Uncertain significance, criteria provided, single submittercurationSema4, Sema4Oct 19, 2021- -
FANCA-related disorder Uncertain:1
Uncertain significance, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesAug 13, 2024The FANCA c.3430C>T variant is predicted to result in the amino acid substitution p.Arg1144Trp. This variant has been reported in the compound heterozygous state with a truncating FANCA variant in an individual with Fanconi anemia (Gille et al. 2012. PubMed ID: 22778927). This variant has also been reported in an individual with breast cancer (Penkert et al. 2018. PubMed ID: 30086788) and a family with Lynch syndrome for which there was an alternate molecular cause (Pirini et al. 2019. PubMed ID: 31655866). This variant is reported in 0.093% of alleles in individuals of European (Non-Finnish) descent in gnomAD and has conflicting interpretations of pathogenicity in ClinVar ranging from likely benign to pathogenic (https://www.ncbi.nlm.nih.gov/clinvar/variation/408171). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.14
T
BayesDel_noAF
Uncertain
0.020
CADD
Benign
22
DANN
Uncertain
1.0
DEOGEN2
Benign
0.41
T;.
Eigen
Benign
-0.16
Eigen_PC
Benign
-0.33
FATHMM_MKL
Benign
0.25
N
LIST_S2
Benign
0.86
D;D
M_CAP
Uncertain
0.23
D
MetaRNN
Uncertain
0.62
D;D
MetaSVM
Benign
-0.41
T
MutationAssessor
Uncertain
2.3
M;M
PrimateAI
Benign
0.25
T
PROVEAN
Uncertain
-4.2
D;D
REVEL
Uncertain
0.46
Sift
Uncertain
0.0090
D;D
Sift4G
Uncertain
0.022
D;D
Polyphen
1.0
D;.
Vest4
0.82
MVP
0.97
ClinPred
0.12
T
GERP RS
3.2
RBP_binding_hub_radar
0.92
RBP_regulation_power_radar
2.0
Varity_R
0.051
gMVP
0.31

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs143671872; hg19: chr16-89813075; API